GloPID-R and partners UKCDR & ISARIC further COVID-19 response

Two further achievements this month attest to the continuing response effort to the COVID-19 pandemic by GloPID-R and our partners.

February 3, 2021 saw both the launch of the UKCDR-GloPID-R COVID CIRCLE Researcher Coordination Platform and the publication in The Lancet Infectious Diseases of a letter, signed by ISARIC and GloPID-R Long COVID Forum Working Group, following the Long COVID Forum.

UKCDR-GloPID-R COVID CIRCLE Researcher Coordination Platform

The public website UKCDR–GloPID-R COVID CIRCLE Researcher Coordination Platform was launched to facilitate information sharing on COVID-19 research and bring together the global research community working on COVID-19 research, in and for low resource settings.

Key features of the platform are:

In order to be of maximum benefit to the global research community, the platform must be kept up to date with as much information as possible. UKCDR & GloPID-R ask you to share this resource with your colleagues and research teams and contribute by sending events, research funding data, funding calls or valuable resources to be featured on the website to: covid19@ukcdr.org.uk.

Long COVID: tackling a multifaceted condition requires a multidisciplinary approach

The Lancet Infectious Diseases
Alice Norton, Piero Olliaro, Louise Sigfrid, Gail Carson, Claire Hastie, Charu Kaushic, Geneviève Boily-Larouche, Jake C Suett, Margaret O’Hara

In their correspondence, Long COVID: tackling a multifaceted condition requires a multidisciplinary approach, published in The Lancet Infectious Diseases the authors, members of the GloPID-R and ISARIC Long COVID Forum Working Group, described the content and discussions of the Long COVID Forum which took place on December 9-10, 2020.

This global, public forum, organised by ISARIC, GloPID-R and the patient support group, Long COVID Support, was introduced by WHO Director-General Tedros Adhanom Ghebreyesus, and brought together people living with long COVID, interdisciplinary researchers, funders, public health experts, and policy makers.

The aim was to identify research gaps to inform urgent long COVID research and support priorities and the core message was the need to expand research beyond hospitalised patients to improve equity in access to research and reduce health inequalities.

Back